Pseudoaneurysm of the Superficial Temporal Artery: A Complication of Botulinum Toxin Injection

2012 ◽  
Vol 36 (4) ◽  
pp. 982-985 ◽  
Author(s):  
Ghassan S. Skaf ◽  
Nathalie T. Domloj ◽  
Joseph A. Salameh ◽  
Bishara Atiyeh
2021 ◽  
Vol 48 (1) ◽  
pp. 149-150
Author(s):  
Elise D. Martin ◽  
Stuart Y. Wernikoff ◽  
Joe D. Bernard ◽  
Girish S. Munavalli

Toxins ◽  
2020 ◽  
Vol 12 (4) ◽  
pp. 214 ◽  
Author(s):  
Young-gun Kim ◽  
Jung-Hee Bae ◽  
Hyeyun Kim ◽  
Shuu-Jiun Wang ◽  
Seong Taek Kim

Botulinum toxin type-A (BTX-A) injection for treating chronic migraine (CM) has developed into a new technique covering distinct injection points in the head and neck regions. The postulated analgesic mechanism implies that the injection should be administered to sensory nerves rather than to muscles. This study aimed to determine the topographical site of the auriculotemporal nerve (ATN) and to propose the effective injection points for treating CM. ATNs were investigated on 36 sides of 25 Korean cadavers. The anatomical structures of the ATN were investigated focusing on the temporal region. A right-angle ruler was positioned based on two clearly identifiable orthogonal reference lines based on the canthus and tragus as landmarks, and photographs were taken. The ATN appeared superficially in the anterosuperior region of the tragus. The nerve is located deeper than the superficial temporal artery. And it runs between the artery and the superficial temporal vein. In the superficial layer, it is divided into anterior and posterior divisions. The anterior division runs in a superior direction, while the posterior division runs in front of the ear and the several branches are distributed to the skin. We suggest that the optimal BTX-A injection points for CM are in the temporal region. The first point is about 2 cm anterior and 3 cm superior to two orthogonal reference lines defined based on the tragus and canthus, and the second point is about 4 cm superior to the first point. The third and fourth points are recommended about 2 cm superior to the first point, but respectively 1 cm anterior and posterior to it.


2017 ◽  
pp. 90-108

Diplopia is described as being intractable when there is inability to both fuse the two images and suppress the second image. Intractable diplopia persists despite achieving ocular alignment using either prisms, lenses,vision therapy,extraocular muscle surgery, or botulinum toxin injection. Treatment usually resorts to occluding or fogging the patient’s nondominant eye. Often times, however, adults having other causative mechanisms for supposedly persistent diplopia are able to achieve comfortable single vision with treatment that either establishes fusion or reactivates a preexisting sensory adaptation. This case series reviews these other causes of diplopia.


Sign in / Sign up

Export Citation Format

Share Document